Monashee Investment Management LLC Replimune Group, Inc. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$30.22 - $45.57 $755,500 - $1.14 Million	-25,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$23.5 - $52.65 $587,500 - $1.32 Million	25,000 New	25,000 $954,000
Q3 2020 Nov 13, 2020	SELL	$18.85 - $27.0 $1.06 Million - $1.51 Million	-56,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$9.76 - $25.95 $546,560 - $1.45 Million	56,000 New	56,000 $1.39 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.